Proliferation of hepatic peroxisomes in rats following the intake of green or black tea

Toxicology Letters

Volumn 109, Issue 1-2, 1999, Pages 69-76

  Bu Abbas, Ali ^a   Dobrota, Miloslav ^a   Copeland, Emma ^a   Clifford, Michael N ^a   Walker, Ron ^a   Ioannides, Costas ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

Cytochromes P450; Flavonoids; Green tea, Black tea; Peroxisomal proliferation; Peroxisomes

Indexed keywords

CAFFEINE; CATECHIN; EPICATECHIN; EPICATECHIN 3 GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; FLAVANOID; FLAVANOL DERIVATIVE; LAURIC ACID; PALMITOYL COENZYME A; PALMITOYL COENZYME A OXIDASE; PEROXISOME PROLIFERATOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CHEMICAL COMPOSITION; CONTROLLED STUDY; DIETARY INTAKE; DOSE RESPONSE; ELECTRON MICROSCOPY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROXYLATION; LIVER TOXICITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TEA;

ANIMALS; BLOTTING, WESTERN; BODY WEIGHT; DOSE-RESPONSE RELATIONSHIP, DRUG; LAURIC ACIDS; LIVER; MALE; MICROBODIES; MICROSCOPY, ELECTRON; PALMITOYL COENZYME A; PEROXISOME PROLIFERATORS; RATS; RATS, WISTAR; TEA;

ANIMALIA; CAMELLIA SINENSIS;

EID: 0032887319     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(99)00119-8     Document Type: Article

References (34)

1. Amacher D.E., Beck R., Schomaker S.J., Kenny C.V. Hepatic microsomal enzyme induction, β-oxidation, and cell proliferation following administration of clofibrate, gemfibrozil, or benzafibrate in the CD rat. Toxicol. Appl. Pharmacol. 142:1997;143-150.
2. Ayalogu E.O., Snelling J., Lewis D.F.V., Talwar S., Clifford M.N., Ioannides C. Induction of hepatic CYP1A2 by the oral administration of caffeine to rats: lack of association with the Ah locus. Biochim. Biophys. Acta. 1272:1995;89-94.
3. Ayrton A.D., Ioannides C., Parke D.V. Induction of the cytochrome P450I and IV families and peroxisomal proliferation in the liver of rats treated with benoxaprofen: Possible implications in its hepatotoxicity. Biochem. Pharmacol. 42:1991;109-115.
4. Barber E.D., Astill B.D., Moran E.J., Schneider B.F., Gray T.J.B., Lake B.G., Evans J.G. Peroxisome induction studies on seven phthalate esters. Toxicol. Indust. Health. 3:1987;7-22.
5. Bronfman M., Inestrosa N.C., Leighton F. Fatty acid oxidation by human liver peroxisomes. Biochem. Biophys. Res. Commun. 88:1979;1030-1036.
6. Bu-Abbas A., Clifford M.N., Walker R., Ioannides C. Selective induction of rat hepatic CYP1 and CYP4 proteins and of peroxisomal proliferation by green tea. Carcinogenesis. 15:1994;2575-2579.
7. Bu-Abbas A., Clifford M.N., Walker R., Ioannides C. Fractionation of green tea extracts: correlation of antimutagenic effect with flavanol content. J. Sci. Fd. Agric. 75:1997;453-462.
8. Bu-Abbas A., Clifford M.N., Walker R., Ioannides C. Modulation of hepatic cytochrome P450 activity and carcinogen bioactivation by tea: contribution of caffeine and flavanols. Environm. Toxicol. Pharmacol. 7:1999;41-47.
9. Cariot P., Barrat E., Mejean L., Pointel J.P., Drouin P., Debbry G. Fenofibrate and human liver: Lack of proliferation of peroxisomes. Arch. Toxicol. 53:1983;151-163.
10. Castle P.J., Merdink J.L., Okita J.R., Wrighton S.A., Okita R.T. Human liver lauric acid hydroxylase activities. Drug Metab. Disp. 23:1995;1037-1043.
11. Clarke S.E., Baldwin S.J., Bloomer J.C., Ayrton A.D., Sozio R.S., Chenery R.J. Lauric acid as a model substrate for the simultaneous determination of cytochrome P450 2E1 and 4A in hepatic microsomes. Chem. Res. Toxicol. 7:1994;836-842.
12. Diaz M.J., Chinje E., Kentish P., Jarnot B., George M., Gibson G.G. Chloritrifluoroethylene trimer and tetramer are inducers of the CYP4A subfamily. Biochem. Pharmacol. 46:1993;1076-1080.
13. Fan C.Y., Pan J., Chu R. et al. Hepatocellular and hepatic peroxisomal alterations in mice with disrupted peroxisomal fatty acyl-coenzyme A oxidase gene. J. Biol. Chem. 271:1996;24698-24710.
14. Gibson G.G. Co-induction of cytochrome P4504A1 and peroxisome proliferation: A causal or casual relationship? Xenobiotica. 22:1992;1101-1109.
15. Harbowy M.E., Balentine D.A. Tea chemistry. Crit. Rev. Plant Sci. 16:1997;415-480.
16. Ioannides C., Parke D.V. Mechanism of induction of hepatic drug metabolising enzymes by a series of barbiturates. J. Pharm. Pharmacol. 27:1975;739-749.
17. Issemann I., Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature (Lond.). 347:1990;645-650.
18. Johnson E.F., Palmer C.N.A., Griffin K.J., Hsu M.-H. Role of the peroxisome proliferator-activated receptor in cytochrome P450 4A gene regulation. FASEB J. 10:1996;1241-1248.
19. Lake B.G. Mechanisms of hepatocarcinogenicity of peroxisome-proliferating drugs and chemicals. Annu. Rev. Pharmacol. Toxicol. 35:1995;483-507.
20. Lake, B.G., Lewis, D.F.V., 1996. The CYP4 family. In: Ioannides, C. (Ed.), Cytochromes cytochrome P450: Metabolic and Toxicological Aspects. CRC Press, Boca Raton, pp. 271-297.
21. Lowry O.H., Rosebrough N.J., Farr A.L., Randall A.J. Protein determination with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-271.
22. Marsman D.S., Cattley R.C., Conway J.G., Popp J.A. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferator di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyridinylthio]acetic acid (Wy-14,643) in rats. Cancer Res. 48:1988;6739-6744.
23. Martinez-Larrañaga M.R., Anadón A., Diaz M.J., Fernandez R., Sevil B., Fernandez-Cruz M.L., Fernandez M.C., Martinez M.A., Anton R. Induction of cytochrome P4501A1 and P4504A1 activities and peroxisomal proliferation by fumonisin B1. Toxicol. Appl. Pharmacol. 141:1996;185-194.
24. Parker, G.L., Orton, T.C., 1980. Induction by oxyisobutyrates of hepatic and kidney hydroxylation of fatty acids. In: Gustafsson, J.A. (Ed.), Biochemistry, Biophysics and Regulation of Cytochrome P450. Elsevier/North Holland, Amsterdam, pp. 373-377.
25. Peters J.M., Cattley R.C., Gonzalez F.J. Role of PPARα in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643. Carcinogenesis. 18:1997;2029-2033.
26. Reddy J.K., Lalwani N.D. Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk on hypolipidemic drugs and industrial plasticizers to humans. Crit. Rev. Toxicol. 12:1983;1-58.
27. Reddy J.K., Rao M.S., Azarnoff D.L, Sell S. Mitogenic and carcinogenic effects of a hypolipidemic peroxisome proliferator, [4-chloro-6-(2,3-xylidino)-2-pyridinylthio]acetic acid (Wy-14,643), in rat and mouse liver. Cancer Res. 39:1979;152-161.
28. Rekka E., Ayalogu E.O., Lewis D.F.V., Gibson G.G., Ioannides C. Induction of hepatic microsomal CYP4A activity and of peroxisomal β-oxidation by two non-steroidal anti-inflammatory drugs. Arch. Toxicol. 68:1994;73-78.
29. Roberts R.A., James N.H., Woodyatt N.J., Macdonald N., Tugwood J.D. Evidence for the suppression of apoptosis by the peroxisome proliferator activated receptor alpha (PPARa). Carcinogenesis. 19:1998;43-48.
30. Sharma R., Lake B.G., Foster J., Gibson G.G. Microsomal cytochrome P-452 induction and peroxisome proliferation by hypolipidaemic agents in rat liver. Biochem. Pharmacol. 37:1988;1193-1201.
31. Thomas H., Schladt L., Knehr M., Oesch F. Effect of diabetes and starvation in the activity of rat liver epoxide hydrolases, glutathione S-transferases and peroxisomal β-oxidation. Biochem. Pharmacol. 38:1989;4291-4297.
32. Tugwood J.D., Aldridge T.C., Lambe K.G., MacDonald N., Woodyatt N.J. Peroxisome proliferator-activated receptors: Structure and function. Ann. N.Y. Acad. Sci. 804:1996;252-265.
33. Wang Z.Y., Huang M.-T., Lou Y.-R., Xie J.-G., Reuhl K.R., Newmark H.L., Ho C.-T., Yang C.S., Conney A.H. Inhibitory effects of black tea, green tea, decaffeinated black tea, and decaffeinated green tea on ultraviolet B light-induced skin tumorigenesis in 7,12-dimethylbenz(a)anthracene-initiated SKH-1 mice. Cancer Res. 54:1994;3428-3435.
34. Zanelli U., Puccini P., Acerbi D., Ventura P., Gervasi P.G. Induction of peroxisomal β-oxidation and P-450 4A-dependent activities by pivalic and trichloroacetic acid in rat liver and kidney. Arch. Toxicol. 70:1996;145-149.